Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FC6J3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,487
Award facts
- Contract value 100% obligated
- $17,486.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,486.91 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 ml syringes on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, aligning with the vendor's corporate headquarters location. Stelara is a biologic immunosuppressant medication used to treat conditions including rheumatoid arthritis, psoriasis, and inflammatory bowel disease, representing a specialized pharmaceutical procurement typical of federal medical supply needs.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs and the Defense Health Agency. AmerisourceBergen Drug Corp's extensive federal contract portfolio and competitive positioning demonstrate its established capability as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FC6J3?
SPE2DB25FC6J3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FC6J3 worth?
The government has obligated $17,487 on SPE2DB25FC6J3.
Is contract SPE2DB25FC6J3 an order under another contract?
Yes. SPE2DB25FC6J3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC6J3 competed?
The extent of competition for SPE2DB25FC6J3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award